Trizell Ltd

Where the EU money came from

Funding by EU programme. Amounts are Trizell Ltd's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• EVERRESTPartner

  Does vascular endothelial growth factor gene therapy safely improve outcome in severe early-onset fetal growth restriction?

  FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

  €1.4Mtheir share
• BIOMAGSCARPartner

  Biodegradable Magnetic Stent for Coronary Artery Luminal Regeneration

  FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

  €84ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Queen Mary University of LondonUnited Kingdom · 2 shared projects
• Ita-Suomen YliopistoFinland · 2 shared projects
• Euram LimitedUnited Kingdom · 2 shared projects
• Magnus Invention Management LtdUnited Kingdom · 2 shared projects
• University College LondonUnited Kingdom · 1 shared project
• Lunds UniversitetSweden · 1 shared project
• University College LondonUnited Kingdom · 1 shared project
• Universitaetsklinikum Hamburg-EppendorfGermany · 1 shared project
• Consorci Institut D'Investigacions Biomediques August Pi i SunyerSpain · 1 shared project
• Yale UniversityUnited States · 1 shared project
• University College London Hospitalsnhs Foundation TrustUnited Kingdom · 1 shared project
• Qualimed Innovative Medizinprodukte GmbHGermany · 1 shared project
• Innvotek LtdUnited Kingdom · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• diabetes
• embryology
• fetal medicine
• gene therapy
• immunotherapy
• nano-materials
• radiology
• vascular diseases